The high-stakes question in this illustrative case is not simply what comes after epinephrine. It is when upper-airway involvement makes airway control the intervention that cannot wait.
Consider this illustrative case: a 21-year-old man develops facial flushing, hives, lip and tongue swelling, wheeze, and dyspnea minutes after eating a dessert at a campus event. He has known peanut allergy, asthma treated intermittently with albuterol, and takes propranolol for migraine prevention. In the emergency department, he is anxious, hoarse, using accessory muscles, and producing inspiratory stridor. His blood pressure is 86/44 mmHg, heart rate 132/min, and oxygen saturation 89% despite supplemental oxygen.
This is anaphylaxis with upper-airway obstruction, bronchospasm, and shock until proven otherwise. The airway plan and anaphylaxis treatment should begin together; neither should wait for the other to fail.
The wheeze is not the whole respiratory problem
Asthma is an important distractor in food-triggered anaphylaxis. Diffuse wheezing may reflect bronchospasm, but hoarseness, stridor, progressive tongue swelling, and a sensation of throat closure indicate upper-airway involvement. Hypotension and urticaria make an isolated asthma exacerbation an inadequate explanation.
| Alternative | Discriminating findings | Immediate implication |
|---|---|---|
| Severe asthma flare | Wheeze, prolonged expiration, hyperinflation, fatigue; no convincing mucocutaneous reaction or shock | Treat bronchospasm, but give epinephrine if anaphylaxis remains possible |
| Foreign-body aspiration | Sudden focal choking, asymmetric breath sounds, localized stridor | Pursue an airway foreign-body pathway; diffuse hives and hypotension point elsewhere |
| Bradykinin-mediated angioedema | Tongue or oropharyngeal swelling, usually without urticaria or bronchospasm | Prioritize airway management; antihistamines and steroids are not reliable rescue therapy |
| Panic or functional upper-airway symptoms | Anxiety and dyspnea without objective hypoxemia, shock, or progressive edema | Do not use anxiety to explain away measurable airway and circulatory compromise |
The combination of a likely allergen exposure, rapidly progressive skin or mucosal findings, respiratory compromise, and hypotension is sufficient to treat clinically. Tryptase or other testing may help later when the diagnosis is uncertain, but testing must not delay treatment, and a normal tryptase result does not exclude anaphylaxis.
Treat the airway before it becomes an airway emergency
Call for experienced airway help early. Give intramuscular epinephrine promptly, typically 0.3–0.5 mg of the 1 mg/mL preparation in the anterolateral thigh for an adult, and repeat it—often after about 5 minutes—according to the local anaphylaxis protocol when airway, breathing, or circulation problems persist. Establish IV or intraosseous access, provide high-concentration oxygen, begin appropriate crystalloid resuscitation for shock, and use continuous cardiac and oxygenation monitoring.
The patient may remain semi-recumbent if that is the only position in which breathing is tolerable, but he should not be allowed to stand or walk. Avoid sudden postural changes. A patient with airway and breathing problems may need a different position from one whose dominant problem is hypotension; reassess continuously rather than forcing a single posture.
Inhaled albuterol or ipratropium can be added for persistent bronchospasm. They are adjuncts, not substitutes for epinephrine. A patient with food-triggered respiratory distress should not receive repeated nebulizers while parenteral anaphylaxis treatment is postponed.
The airway threshold is clinical rather than tied to one oxygen-saturation number. Worsening stridor, progressive tongue or oropharyngeal swelling, a deteriorating voice, inability to handle secretions, increasing fatigue, inadequate oxygenation or ventilation, or a trajectory toward altered consciousness should prompt controlled airway management before complete obstruction.
This patient already has several warning signs: hoarseness, stridor, visible tongue swelling, severe work of breathing, hypoxemia, and shock. The most experienced available operator should prepare for intubation using the department’s difficult-airway plan. Preoxygenation, suction, rescue oxygenation, an appropriate advanced airway device, and a front-of-neck rescue plan should be ready before induction. The exact technique depends on operator expertise, anatomy, equipment, and local protocol; the non-negotiable principle is to maximize first-pass success and avoid repeated traumatic attempts.
Nebulized epinephrine may temporarily reduce upper-airway edema, but it must not delay definitive airway management when obstruction is critical. The goal is adequate tissue oxygenation, not placing a tube at any cost; however, waiting until the patient is obtunded or in respiratory arrest makes the airway more difficult and the rescue options less reliable.
What propranolol changes—and what it does not
Propranolol is clinically relevant, but it does not change the first-line treatment. Epinephrine remains the treatment for anaphylaxis. Beta-blockade may blunt compensatory cardiovascular responses and may reduce the apparent response to epinephrine, but the true contribution of beta-blockers to severity and treatment resistance remains uncertain.
The old shorthand of unopposed alpha stimulation is too simple to serve as the entire explanation. Persistent shock may reflect vasodilation, capillary leak, bronchospasm, myocardial effects, inadequate drug delivery, or several mechanisms at once. Do not label the reaction epinephrine-resistant after one dose, and do not withhold epinephrine because the patient takes a beta-blocker.
If cardiovascular or respiratory compromise persists after two appropriate intramuscular doses, obtain expert help for a monitored IV epinephrine infusion. Definitions of refractory anaphylaxis vary among guidelines, but a single IM dose does not justify switching to glucagon. Shock-directed fluid resuscitation and airway management should proceed in parallel rather than wait for the infusion or either intervention to fail.
Glucagon can be considered as an adjunct—not as a substitute—when cardiovascular compromise remains refractory despite an epinephrine infusion and adequate fluid resuscitation in a patient taking a beta-blocker. Its proposed advantage is activation of a non-beta-adrenergic pathway that increases intracellular cyclic AMP.
Glucagon is not a replacement for epinephrine, fluids, airway control, or critical care support. Evidence for its use in anaphylaxis is limited, dosing varies among protocols, and vomiting is an important adverse effect in a patient with a threatened airway. Verify the local refractory-anaphylaxis protocol, prepare suction, and never allow the search for glucagon to delay airway intervention.
Common traps in this presentation
- Calling it asthma first: Wheeze is prominent, but hives, angioedema, hypotension, and rapid food-linked onset identify a multisystem process.
- Waiting for a second blood pressure reading: The patient already has objective shock and airway compromise. Treatment should not wait for laboratory confirmation.
- Using albuterol as the main therapy: Bronchodilators treat bronchospasm; they do not reverse vasodilation, capillary leak, or laryngeal edema.
- Giving antihistamines or steroids before epinephrine: These may have limited adjunctive roles after initial stabilization but do not treat life-threatening airway or circulatory problems quickly.
- Giving a large IV epinephrine bolus to a patient with a pulse: In a spontaneously perfusing patient, undiluted IV bolus epinephrine can cause severe hypertension, dysrhythmia, myocardial ischemia, and cardiovascular collapse. Refractory IV therapy requires experienced clinicians, appropriate dilution, and monitoring.
- Waiting for complete obstruction: Stridor and progressive voice or tongue changes are early airway warnings, not findings to observe passively.
Practical takeaways
- Stridor, hoarseness, and tongue swelling are upper-airway findings; wheeze alone does not describe the whole problem.
- In severe anaphylaxis, give IM epinephrine immediately while preparing the airway and treating shock.
- A history of asthma should not delay epinephrine, and a history of propranolol should not make epinephrine seem futile.
- Intubate based on progression, airway findings, oxygenation, ventilation, and fatigue—not on a single arbitrary threshold.
- Glucagon is a rescue adjunct for selected beta-blocked patients with refractory cardiovascular compromise despite epinephrine infusion and adequate fluid resuscitation, not the next step after one IM dose.
- The safest airway is usually the one planned and secured before edema, exhaustion, and hypoxemia remove the margin for error.
